Brian Berry
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 10
- Oncology 10
- Viral-associated cancers and disorders 5
- Co-authors
- Randy D. Gascoyne (11 shared papers)Joseph M. Connors (10 shared papers)Laurie H. Sehn (4 shared papers)Mukesh Chhanabhai (3 shared papers)Judy Sutherland (2 shared papers)Karamjit Gill (2 shared papers)Richard Klasa (2 shared papers)Paul Hoskins (1 shared paper)
- Journals
- PLoS ONE (3 papers)Blood (2 papers)Transfusion (2 papers)Vox Sanguinis (2 papers)Hematological Oncology (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Brian Berry
26 papers receiving 1.6k citations
Brian Berry's Hit Papers
Peers
Comparison fields: 5 of 86
- Pathology and Forensic Medicine 1.2k
- Genetics 411
- Oncology 768
- Neurology 395
- Biochemistry 56
Countries citing papers authored by Brian Berry
This map shows the geographic impact of Brian Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Berry more than expected).
Fields of papers citing papers by Brian Berry
This network shows the impact of papers produced by Brian Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Berry. The network helps show where Brian Berry may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Berry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP Hit paper breakdown → | 2006 | 1033 |
| 2 | 2011 | 146 | |
| 3 | 2007 | 97 | |
| 4 | 2007 | 46 | |
| 5 | 2009 | 45 | |
| 6 | 2010 | 43 | |
| 7 | 2000 | 43 | |
| 8 | 2010 | 29 | |
| 9 | 1998 | 26 | |
| 10 | 2012 | 22 | |
| 11 | 2017 | 21 | |
| 12 | 2017 | 19 | |
| 13 | 2015 | 18 | |
| 14 | 2018 | 16 | |
| 15 | 1996 | 14 | |
| 16 | 2013 | 9 | |
| 17 | 2015 | 8 | |
| 18 | 2021 | 6 | |
| 19 | 2021 | 6 | |
| 20 | 2011 | 5 |
About Brian Berry
Brian Berry is a scholar working on Pathology and Forensic Medicine, Oncology, Internal Medicine, Biochemistry and Cardiology and Cardiovascular Medicine, having authored 27 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Blood transfusion and management (5 papers), Viral-associated cancers and disorders (5 papers), Venous Thromboembolism Diagnosis and Management (5 papers), Immune Cell Function and Interaction (3 papers), Blood donation and transfusion practices (3 papers), Atrial Fibrillation Management and Outcomes (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.2k citations), Genetics (411 citations), Oncology (768 citations), Neurology (395 citations) and Biochemistry (56 citations). Brian Berry has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn, Mukesh Chhanabhai, Judy Sutherland, Karamjit Gill, Richard Klasa, Paul Hoskins, Kerry J. Savage and C. P. Fitzgerald. Their work appears in journals such as PLoS ONE, Blood, Transfusion, Vox Sanguinis and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.